http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007517840-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2005-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007517840-A |
| titleOfInvention | Acylaminothiazole derivatives, methods for their preparation and use of the derivatives in therapy |
| abstract | The present invention relates to general formula (I) (R 1 is optionally substituted, C 1-6 alkyl or C 3-7 cycloalkyl, thiophene, benzothiophene, pyridinyl, furanyl or optionally substituted. Each of R 2 and R ′ 2 independently of one another represents a hydrogen atom, a halogen atom, hydroxy, C 1-3 alkoxy, C 1-3 alkyl, C 3-7 cycloalkyl, O— Represents a C (O) —C 1-6 alkyl group, or R 2 and R ′ 2 together form an oxo group; R 3 represents a hydrogen atom, hydroxyl, C 1-6 cycloalkyl or Represents C 1-6 alkyl optionally substituted by C 1-3 alkoxy; any of R 4 and R 5 represents a group (Z), and either R 4 or R 5 represents — Represents a C (X) R 6 group; Y represents a single bond, an oxygen atom, a sulfur atom, an optionally substituted C 1-4 alkylene group or —N (W) —; and A and B represent a single bond or a —CH 2 — group; Each independently represents a hydrogen atom, halogen atom, hydroxy group, C 1-3 alkyl, C 1-3 alkoxy, trifluoromethyl, trifluoromethoxy or —O—CHF 2 group; X represents O or S; R 6 represents an optionally substituted C 1-6 alkoxy group, hydroxy or —NR 7 R 8 ; and R 7 and R 8 are, independently of each other, a hydrogen atom; A substituted C 1-6 alkyl group; represents either an optionally substituted C 3-7 cycloalkyl group, a C 1-6 alkoxy or an optionally substituted phenyl; or R 7 and R 8, have a these Together with that nitrogen atom, an aziridine, azetidine, pyrrolidine, piperidine, form a morpholine or benzo piperidine ring.) Relates to compounds having the. The compounds of the invention take the form of bases, acid addition salts or hydrates. The invention also relates to the use of said compounds in therapy. |
| priorityDate | 2004-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 172.